Drug development

Upstream Development for High Yield Biologics Production 

Biologics, Drug development, Manufacturing

The New Era of Biosimilar Development: Seizing the Opportunity Under EMA’s Streamlined Guidelines

Biosimilars, Clinical trials, Drug development, EMA, FDA, Mabion, Regulatory

In-Process Testing for Drugs in the Pharmaceutical Industry

Analytics, Drug development

Role of Stable Cell Line in Biopharmaceutical Manufacturing 

Drug development, Drug product, Manufacturing

Time to Market Strategy – 5 CDMO Tactics to Speed Up Biologic Launches

Biologics, Drug development, Manufacturing

CHO Cell Lines for Recombinant Protein Production

Drug development, Drug product, Manufacturing

Leading European CDMO for Drug Product Manufacturing

Drug development, Drug product, Manufacturing

Antibodies Development Best Practices for CDMO Collaboration

Drug development, Manufacturing, Monoclonal antibody

Qualitative Analysis of Host Cell Proteins using Mass Spectrometry

Analytics, Drug development, Drug product, Drug substance